Literature DB >> 25300723

Small hepatocellular carcinoma: MRI findings for predicting tumor growth rates.

Reena C Jha1, Paulo A Zanello2, Xai Mai Nguyen3, Marieta Pehlivanova4, Lynt B Johnson5, Thomas Fishbein5, Kirti Shetty5.   

Abstract

RATIONALE AND
OBJECTIVES: Current clinical practice favors imaging rather than biopsy to diagnose hepatocellular carcinoma (HCC). There is a need to better understand tumor biology and aggressiveness of HCC. Our goal is to investigate magnetic resonance imaging (MRI) features of HCC that are associated with faster growth rates (GRs).
MATERIALS AND METHODS: After approval from institutional review board, a retrospective evaluation was performed of pre-liver transplant patients. Fifty-two patients who developed a >2 cm HCC on serial imaging were included in the study group, with a total of 60 HCCs seen. Precursor foci were identified on serial MRIs before the specific diagnostic features of >2 cm HCC could be made, and GRs and MRI features, including signal on T1- and T2-weighted images (WI), the presence of intralesional steatosis on chemical shift imaging, and enhancement pattern were analyzed. GRs were correlated with imaging features.
RESULTS: The average GR of precursor lesions to >2 cm HCC was determined to be 0.23 cm/mo (standard deviation [SD], 0.32), with a doubling time of 5.26 months (SD, 5.44). The presence of increased signal intensity (SI) on T2-WI was associated with significantly higher growth (P = .0002), whereas increased intensity on T1-WI at the initial study was associated with a significantly lower GR (P = .0162). Furthermore, lesions with hypervascular enhancement with washout pattern had significantly higher GR (P = .0164). There is no evidence of differences in GRs seen in lesions with steatosis.
CONCLUSIONS: Small precursor lesions with increased SI on T2-WI and a washout pattern of enhancement are associated with faster GRs, which may suggest more aggressive tumor biology. These features may be helpful in patient management and surveillance for HCC.
Copyright © 2014 AUR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Liver neoplasms; MR; diagnosis; hepatocellular carcinoma; liver cancer; prognosis prediction

Mesh:

Year:  2014        PMID: 25300723     DOI: 10.1016/j.acra.2014.06.011

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  5 in total

1.  Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI?

Authors:  Sidong Xie; Yao Zhang; Jingbiao Chen; Ting Jiang; Weimin Liu; Dailin Rong; Lin Sun; Linqi Zhang; Bingjun He; Jin Wang
Journal:  Abdom Radiol (NY)       Date:  2021-11-13

Review 2.  Focal liver lesions: Practical magnetic resonance imaging approach.

Authors:  António P Matos; Fernanda Velloni; Miguel Ramalho; Mamdoh AlObaidy; Aruna Rajapaksha; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-08-08

Review 3.  Imaging of hepatocellular carcinoma and image guided therapies - how we do it.

Authors:  Jonathon Willatt; Julie A Ruma; Shadi F Azar; Nara L Dasika; F Syed
Journal:  Cancer Imaging       Date:  2017-03-04       Impact factor: 3.909

Review 4.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

5.  Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.

Authors:  Piyush Nathani; Purva Gopal; Nicole Rich; Adam Yopp; Takeshi Yokoo; Binu John; Jorge Marrero; Neehar Parikh; Amit G Singal
Journal:  Gut       Date:  2020-05-12       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.